{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:54:00Z","timestamp":1792184040645,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG059501"],"award-info":[{"award-number":["R01AG059501"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R03AG059462"],"award-info":[{"award-number":["R03AG059462"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medizinische Hochschule Brandenburg - Theodor Fontane","award":["Internal grant"],"award-info":[{"award-number":["Internal grant"]}]},{"name":"BIOX Stiftung","award":["Basic Research Program"],"award-info":[{"award-number":["Basic Research Program"]}]},{"name":"Universit\u00e4tsklinikum der Ruhr-Universit\u00e4t Bochum"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Heart failure (HF) is a heterogeneous clinical syndrome affecting a growing global population. Due to the high incidence of cardiovascular risk factors, a large proportion of the Western population is at risk for heart failure. Oxidative stress and inflammation play a crucial role in the pathophysiology of heart failure with preserved ejection fraction (HFpEF). While previous studies have demonstrated an association between dysfunctional HDL and heart failure, the specific link between oxidized HDL and HF remains unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this cross-sectional observational study, the antioxidant function of HDL was assessed in 366 patients with suspected heart failure. HFpEF assessment was conducted according to current guidelines. A validated cell-free biochemical assay was used to determine reduced HDL antioxidant function as assessed by increased HDL-lipid peroxide content (HDL\n                      <jats:sub>ox<\/jats:sub>\n                      ), normalized by HDL-C levels and the mean value of a pooled serum control from healthy participants (nHDL\n                      <jats:sub>ox<\/jats:sub>\n                      ; no units). Results were expressed as median with interquartile range (IQR).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Participants with HFpEF (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200988) had 15% higher mean relative levels of nHDL\n                      <jats:sub>ox<\/jats:sub>\n                      than those without heart failure (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009180). Using a basic multivariate model adjusted for age, sex, eGFR and a full multivariate model (adjusted for diabetes, hypertension, atrial fibrillation, LDL cholesterol, hsCRP, and coronary artery disease), nHDL\n                      <jats:sub>ox<\/jats:sub>\n                      was an independent predictor for HFpEF (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). An increase in 1-SD in nHDL\n                      <jats:sub>ox<\/jats:sub>\n                      was associated with a 67% increased risk for HFpEF if compared with participants without heart failure (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HDL antioxidant function is reduced in patients with HFpEF. Improving HDL function is a promising target for early heart failure treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00392-024-02583-3","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T10:08:22Z","timestamp":1736935702000},"page":"232-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Reduced antioxidant high-density lipoprotein function in heart failure with preserved ejection fraction"],"prefix":"10.1007","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8157-9875","authenticated-orcid":false,"given":"Benjamin","family":"Sasko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Kelesidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawa","family":"Kostin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Scharow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Jaensch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Wintrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Christ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ukena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Pagonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"issue":"3","key":"2583_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","volume":"6","author":"PA Heidenreich","year":"2013","unstructured":"Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC et al (2013) Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circulation Heart Fail 6(3):606\u2013619","journal-title":"Circulation Heart Fail"},{"issue":"10120","key":"2583_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","volume":"391","author":"N Conrad","year":"2018","unstructured":"Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP et al (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. The Lancet 391(10120):572\u2013580","journal-title":"The Lancet"},{"issue":"14","key":"2583_CR3","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa1406656","volume":"372","author":"GA Roth","year":"2015","unstructured":"Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL et al (2015) Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med 372(14):1333\u20131341","journal-title":"N Engl J Med"},{"issue":"8","key":"2583_CR4","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/ejhf.567","volume":"18","author":"M Christ","year":"2016","unstructured":"Christ M, Stork S, Dorr M, Heppner HJ, Muller C, Wachter R et al (2016) Heart failure epidemiology 2000\u20132013: insights from the German Federal Health Monitoring System. Eur J Heart Fail 18(8):1009\u20131018","journal-title":"Eur J Heart Fail"},{"issue":"36","key":"2583_CR5","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726","journal-title":"Eur Heart J"},{"key":"2583_CR6","doi-asserted-by":"crossref","unstructured":"Bozkurt B, Coats AJ, Tsutsui H, Abdelhamid M, Adamopoulos S, Albert N, et al (2021) Universal definition and classification of heart failure: a Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail","DOI":"10.1002\/ejhf.2115"},{"issue":"4","key":"2583_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","volume":"8","author":"M Navab","year":"2011","unstructured":"Navab M, Reddy ST, Van Lenten BJ, Fogelman AM (2011) HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol 8(4):222\u2013232","journal-title":"Nat Rev Cardiol"},{"issue":"21","key":"2583_CR8","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1016\/j.jacc.2016.03.538","volume":"67","author":"P Mody","year":"2016","unstructured":"Mody P, Joshi PH, Khera A, Ayers CR, Rohatgi A (2016) Beyond coronary calcification, family history, and C-reactive protein: cholesterol efflux capacity and cardiovascular risk prediction. J Am Coll Cardiol 67(21):2480\u20132487","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl","key":"2583_CR9","doi-asserted-by":"publisher","first-page":"S145","DOI":"10.1194\/jlr.R800036-JLR200","volume":"50 Suppl","author":"M Navab","year":"2009","unstructured":"Navab M, Reddy ST, Van Lenten BJ, Anantharamaiah GM, Fogelman AM (2009) The role of dysfunctional HDL in atherosclerosis. J Lipid Res 50 Suppl(Suppl):S145-149","journal-title":"J Lipid Res"},{"issue":"43","key":"2583_CR10","first-page":"3007","volume":"36","author":"S Zewinger","year":"2015","unstructured":"Zewinger S, Drechsler C, Kleber ME, Dressel A, Riffel J, Triem S et al (2015) Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk. Eur Heart J 36(43):3007\u20133016","journal-title":"Eur Heart J"},{"issue":"17","key":"2583_CR11","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1097\/QAD.0000000000001238","volume":"30","author":"T Kelesidis","year":"2016","unstructured":"Kelesidis T, Jackson N, McComsey GA, Wang X, Elashoff D, Dube MP et al (2016) Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection. AIDS 30(17):2625\u20132633","journal-title":"AIDS"},{"issue":"1","key":"2583_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.clim.2010.06.014","volume":"137","author":"BJ Skaggs","year":"2010","unstructured":"Skaggs BJ, Hahn BH, Sahakian L, Grossman J, McMahon M (2010) Dysfunctional, pro-inflammatory HDL directly upregulates monocyte PDGFRbeta, chemotaxis and TNFalpha production. Clin Immunol 137(1):147\u2013156","journal-title":"Clin Immunol"},{"issue":"12","key":"2583_CR13","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1161\/CIRCRESAHA.113.301684","volume":"113","author":"V Adams","year":"2013","unstructured":"Adams V, Besler C, Fischer T, Riwanto M, Noack F, Hollriegel R et al (2013) Exercise training in patients with chronic heart failure promotes restoration of high-density lipoprotein functional properties. Circ Res 113(12):1345\u20131355","journal-title":"Circ Res"},{"issue":"2","key":"2583_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jacc.2018.10.059","volume":"73","author":"WG Hunter","year":"2019","unstructured":"Hunter WG, McGarrah RW 3rd, Kelly JP, Khouri MG, Craig DM, Haynes C et al (2019) High-density lipoprotein particle subfractions in heart failure with preserved or reduced ejection fraction. J Am Coll Cardiol 73(2):177\u2013186","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2583_CR15","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.jchf.2024.03.007","volume":"12","author":"A Pandey","year":"2024","unstructured":"Pandey A, Patel KV, Segar MW, Shapiro MD, Ballantyne CM, Virani SS et al (2024) Association of high-density lipoprotein parameters and risk of heart failure: a multicohort analysis. JACC Heart Fail 12(7):1242\u20131253","journal-title":"JACC Heart Fail"},{"issue":"11","key":"2583_CR16","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1136\/hrt.2005.063784","volume":"91","author":"PM Bettencourt","year":"2005","unstructured":"Bettencourt PM (2005) Clinical usefulness of B-type natriuretic peptide measurement: present and future perspectives. Heart 91(11):1489\u20131494","journal-title":"Heart"},{"issue":"20","key":"2583_CR17","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.jacc.2011.08.030","volume":"58","author":"PJ Patel","year":"2011","unstructured":"Patel PJ, Khera AV, Jafri K, Wilensky RL, Rader DJ (2011) The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease. J Am Coll Cardiol 58(20):2068\u20132075","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"2583_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111716","volume":"9","author":"T Kelesidis","year":"2014","unstructured":"Kelesidis T, Roberts CK, Huynh D, Martinez-Maza O, Currier JS, Reddy ST et al (2014) A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL. PLoS ONE 9(11):e111716","journal-title":"PLoS ONE"},{"key":"2583_CR19","unstructured":"Roy SS, Nguyen HCX, Angelovich TA, Hearps AC, Huynh D, Jaworowski A, Kelesidis T (2017) Cell-free biochemical fluorometric enzymatic assay for high-throughput measurement of lipid peroxidation in high density lipoprotein. J Visu Exp (128):56325"},{"issue":"17","key":"2583_CR20","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1056\/NEJMoa2400969","volume":"390","author":"CM Gibson","year":"2024","unstructured":"Gibson CM, Duffy D, Korjian S, Bahit MC, Chi G, Alexander JH et al (2024) Apolipoprotein A1 infusions and cardiovascular outcomes after acute myocardial infarction. N Engl J Med 390(17):1560\u20131571","journal-title":"N Engl J Med"},{"issue":"5","key":"2583_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa020245","volume":"347","author":"S Kenchaiah","year":"2002","unstructured":"Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG et al (2002) Obesity and the risk of heart failure. N Engl J Med 347(5):305\u2013313","journal-title":"N Engl J Med"},{"issue":"8","key":"2583_CR22","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","volume":"95","author":"PJ Barter","year":"2004","unstructured":"Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM (2004) Antiinflammatory properties of HDL. Circ Res 95(8):764\u2013772","journal-title":"Circ Res"},{"issue":"11","key":"2583_CR23","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1161\/01.RES.0000225982.01988.93","volume":"98","author":"C Mineo","year":"2006","unstructured":"Mineo C, Deguchi H, Griffin JH, Shaul PW (2006) Endothelial and antithrombotic actions of HDL. Circ Res 98(11):1352\u20131364","journal-title":"Circ Res"},{"issue":"3","key":"2583_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s11883-007-0026-3","volume":"9","author":"M Navab","year":"2007","unstructured":"Navab M, Yu R, Gharavi N, Huang W, Ezra N, Lotfizadeh A et al (2007) High-density lipoprotein: antioxidant and anti-inflammatory properties. Curr Atheroscler Rep 9(3):244\u2013248","journal-title":"Curr Atheroscler Rep"},{"issue":"4","key":"2583_CR25","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10741-020-09916-0","volume":"26","author":"AO Jackson","year":"2021","unstructured":"Jackson AO, Meng J, Tang H, Yin K (2021) High-density lipoprotein-mediated cardioprotection in heart failure. Heart Fail Rev 26(4):767\u2013780","journal-title":"Heart Fail Rev"},{"key":"2583_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.925923","volume":"9","author":"H Jiang","year":"2022","unstructured":"Jiang H, Zhou Y, Nabavi SM, Sahebkar A, Little PJ, Xu S et al (2022) Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis. Front Cardiovasc Med 9:925923","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"2583_CR27","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1172\/JCI118345","volume":"96","author":"BJ Van Lenten","year":"1995","unstructured":"Van Lenten BJ, Hama SY, de Beer FC, Stafforini DM, McIntyre TM, Prescott SM et al (1995) Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 96(6):2758\u20132767","journal-title":"J Clin Invest"},{"issue":"9","key":"2583_CR28","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1172\/JCI67478","volume":"123","author":"Y Huang","year":"2013","unstructured":"Huang Y, Wu Z, Riwanto M, Gao S, Levison BS, Gu X et al (2013) Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex. J Clin Invest 123(9):3815\u20133828","journal-title":"J Clin Invest"},{"key":"2583_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12944-016-0229-0","volume":"15","author":"K Gaal","year":"2016","unstructured":"Gaal K, Tarr T, Lorincz H, Borbas V, Seres I, Harangi M et al (2016) High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus. Lipids Health Dis 15:60","journal-title":"Lipids Health Dis"},{"issue":"5","key":"2583_CR30","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.fertnstert.2015.02.024","volume":"103","author":"J Zhang","year":"2015","unstructured":"Zhang J, Zhang Y, Liu H, Bai H, Wang Y, Jiang C et al (2015) Antioxidant properties of high-density lipoproteins are impaired in women with polycystic ovary syndrome. Fertil Steril 103(5):1346\u20131354","journal-title":"Fertil Steril"},{"key":"2583_CR31","doi-asserted-by":"crossref","unstructured":"Rojas M, Prado Y, Tapia P, Carre\u00f1o LJ, Cabello-Verrugio C, Simon F (2022) Oxidized high-density lipoprotein induces endothelial fibrosis promoting hyperpermeability, hypotension, and increased mortality. Antioxidants (Basel) 11(12):2469","DOI":"10.3390\/antiox11122469"},{"key":"2583_CR32","doi-asserted-by":"crossref","unstructured":"Pagonas N, Mueller R, Weiland L, Jaensch M, Dammermann W, Seibert FS, Hillmeister P, Buschmann I, Christ M, Ritter O, Westhoff TH, Sasko B, Kelesidis T (2024) Oxidized high-density lipoprotein associates with atrial fibrillation. Heart Rhythm 21(4):362\u2013369","DOI":"10.1016\/j.hrthm.2023.11.024"},{"issue":"4","key":"2583_CR33","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nm.2124","volume":"16","author":"V Rudolph","year":"2010","unstructured":"Rudolph V, Andrie RP, Rudolph TK, Friedrichs K, Klinke A, Hirsch-Hoffmann B et al (2010) Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med 16(4):470\u2013474","journal-title":"Nat Med"},{"issue":"11","key":"2583_CR34","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/jbt.21588","volume":"28","author":"VS Soumyarani","year":"2014","unstructured":"Soumyarani VS, Jayakumari N (2014) Oxidized HDL induces cytotoxic effects: implications for atherogenic mechanism. J Biochem Mol Toxicol 28(11):481\u2013489","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"2583_CR35","doi-asserted-by":"publisher","first-page":"H190","DOI":"10.1152\/ajpheart.00243.2016","volume":"311","author":"RP Iyer","year":"2016","unstructured":"Iyer RP, Jung M, Lindsey ML (2016) MMP-9 signaling in the left ventricle following myocardial infarction. Am J Physiol Heart Circ Physiol 311(1):H190-198","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"2583_CR36","doi-asserted-by":"publisher","first-page":"531","DOI":"10.31083\/j.rcm.2020.04.154","volume":"21","author":"N Nair","year":"2020","unstructured":"Nair N (2020) Epidemiology and pathogenesis of heart failure with preserved ejection fraction. Rev Cardiovasc Med 21(4):531\u2013540","journal-title":"Rev Cardiovasc Med"},{"issue":"5","key":"2583_CR37","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","volume":"27","author":"G Torre-Amione","year":"1996","unstructured":"Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27(5):1201\u20131206","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2583_CR38","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/ndt\/gft080","volume":"28","author":"T Speer","year":"2013","unstructured":"Speer T, Zewinger S, Fliser D (2013) Uraemic dyslipidaemia revisited: role of high-density lipoprotein. Nephrol Dial Transplant 28(10):2456\u20132463","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2583_CR39","doi-asserted-by":"publisher","first-page":"718","DOI":"10.2174\/157016112803520710","volume":"10","author":"U Landmesser","year":"2012","unstructured":"Landmesser U (2012) High density lipoprotein - should we raise it? Curr Vasc Pharmacol 10(6):718\u2013719","journal-title":"Curr Vasc Pharmacol"},{"key":"2583_CR40","doi-asserted-by":"crossref","unstructured":"Samadi S, Mehramiz M, Kelesidis T, Mobarhan MG, Sahebkar AH, Esmaily H, Moohebati M, Farjami Z, Ferns GA, Mohammadpour AH, Avan A (2019) High-density lipoprotein lipid peroxidation as a molecular signature of the risk for developing cardiovascular disease: Results from MASHAD cohort. J Cell Physiol 234(9):16168\u201316177","DOI":"10.1002\/jcp.28276"},{"issue":"17","key":"2583_CR41","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1097\/QAD.0000000000001642","volume":"31","author":"TA Angelovich","year":"2017","unstructured":"Angelovich TA, Hearps AC, Oda MN, Borja MS, Huynh D, Homann S et al (2017) Dysfunctional high-density lipoprotein from HIV+ individuals promotes monocyte-derived foam cell formation in vitro. AIDS 31(17):2331\u20132336","journal-title":"AIDS"},{"issue":"1","key":"2583_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12944-021-01608-4","volume":"21","author":"SM Flaherty","year":"2022","unstructured":"Flaherty SM, Wood EK, Ryff CD, Love GD, Kelesidis T, Berkowitz L et al (2022) Race and sex differences in HDL peroxide content among American adults with and without type 2 diabetes. Lipids Health Dis 21(1):18","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2583_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/ijo.2016.190","volume":"41","author":"WS Davidson","year":"2017","unstructured":"Davidson WS, Inge TH, Sexmith H, Heink A, Elder D, Hui DY et al (2017) Weight loss surgery in adolescents corrects high-density lipoprotein subspecies and their function. Int J Obes (Lond) 41(1):83\u201389","journal-title":"Int J Obes (Lond)"},{"issue":"12","key":"2583_CR44","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1177\/2047487319848199","volume":"26","author":"N Pagonas","year":"2019","unstructured":"Pagonas N, Vlatsas S, Bauer F, Seibert FS, Sasko B, Buschmann I et al (2019) The impact of aerobic and isometric exercise on different measures of dysfunctional high-density lipoprotein in patients with hypertension. Eur J Prev Cardiol 26(12):1301\u20131309","journal-title":"Eur J Prev Cardiol"},{"issue":"8","key":"2583_CR45","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3851\/IMP2756","volume":"19","author":"MV Zanni","year":"2014","unstructured":"Zanni MV, Kelesidis T, Fitzgerald ML, Lo J, Abbara S, Wai B et al (2014) HDL redox activity is increased in HIV-infected men in association with macrophage activation and non-calcified coronary atherosclerotic plaque. Antivir Ther 19(8):805\u2013811","journal-title":"Antivir Ther"},{"issue":"3","key":"2583_CR46","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/biof.1489","volume":"45","author":"S Samadi","year":"2019","unstructured":"Samadi S, Abolbashari S, Meshkat Z, Mohammadpour AH, Kelesidis T, Gholoobi A et al (2019) Human T lymphotropic virus type 1 and risk of cardiovascular disease: High-density lipoprotein dysfunction versus serum HDL-C concentrations. BioFactors 45(3):374\u2013380","journal-title":"BioFactors"},{"key":"2583_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1476-511X-11-87","volume":"11","author":"T Kelesidis","year":"2012","unstructured":"Kelesidis T, Reddy ST, Huynh D, Meriwether D, Fogelman AM, Navab M et al (2012) Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity. Lipids Health Dis 11:87","journal-title":"Lipids Health Dis"},{"issue":"12","key":"2583_CR48","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1194\/jlr.D018937","volume":"52","author":"T Kelesidis","year":"2011","unstructured":"Kelesidis T, Currier JS, Huynh D, Meriwether D, Charles-Schoeman C, Reddy ST et al (2011) A biochemical fluorometric method for assessing the oxidative properties of HDL. J Lipid Res 52(12):2341\u20132351","journal-title":"J Lipid Res"},{"issue":"45","key":"2583_CR49","doi-asserted-by":"publisher","first-page":"30825","DOI":"10.1074\/jbc.M109.047605","volume":"284","author":"A Undurti","year":"2009","unstructured":"Undurti A, Huang Y, Lupica JA, Smith JD, DiDonato JA, Hazen SL (2009) Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle. J Biol Chem 284(45):30825\u201330835","journal-title":"J Biol Chem"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-024-02583-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-024-02583-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-024-02583-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T13:02:18Z","timestamp":1769000538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-024-02583-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2583"],"URL":"https:\/\/doi.org\/10.1007\/s00392-024-02583-3","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The assay of HDL\n                      ox\n                      is relevant to the patent PCT\/US2015\/018147 (to TK). The other authors declare no conflict of interest. CU is an editorial board member.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from all participants. The study was approved by the local ethics committees of the medical association of Brandenburg (Nr. AS69bB\/2016) and of the Ruhr University of Bochum (Nr. 15\u20135279) in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement"}}]}}